Midline malignant B-cell lymphoma with leukemic transformation. 1992

J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
Department of Oral Surgery, Kochi Medical School, Japan.

This article presents a case of lethal midline granuloma on the palate of a 44-year-old woman, which had been identified histologically as B-cell lymphoma with leukemic transformation in the terminal stages. At the first visit, physical and laboratory examinations showed no remarkable findings except for a necrotizing ulcer of the palate, and the biopsy specimens only showed massive inflammatory cell infiltration and necrosis of the granulation tissue. There was a short-term resolution after treatment with cyclophosphamide and prednisolone, but the disease reactivated and the necrotic ulcerative lesion progressively advanced into the nasal cavity. Specimens from the third biopsy exhibited histologic features that were consistent with malignant lymphoma of the diffuse, mixed B-cell type. Chemotherapy with the regimen of cyclophosphamide, doxorubicin, vincristine, and prednisolone was adopted but was interrupted after a short time because of bone marrow suppression. Subsequently, large numbers of enlarged abnormal lymphocytes with a few vacuoles in the cytoplasm appeared in the circulating blood, indicating leukemic transformation of the midline lymphoma. The patient died on the seventh day after the initiation of chemotherapy. In the presentation of this case, the authors mention clinically important matters regarding midline lethal lymphoma and briefly discuss the pathophysiology and pathogenesis.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006103 Granuloma, Lethal Midline A condition that is characterized by inflammation, ulceration, and perforation of the nose and the PALATE with progressive destruction of midline facial structures. This syndrome can be manifested in several diseases including the nasal type of EXTRANODAL NK-T-CELL LYMPHOMA and GRANULOMATOSIS WITH POLYANGIITIS. Granuloma Gangraenescens,Lethal Midline Granuloma,Polymorphic Reticulosis,Granulomas, Lethal Midline,Lethal Midline Granulomas,Midline Granuloma, Lethal,Midline Granulomas, Lethal,Polymorphic Reticuloses,Reticuloses, Polymorphic,Reticulosis, Polymorphic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
January 1988, Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
October 2011, Blood,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
November 2012, Blood,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
April 1982, Nihon Kyobu Shikkan Gakkai zasshi,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
May 1996, Journal of the American Academy of Dermatology,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
November 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
November 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
April 2022, Zhonghua bing li xue za zhi = Chinese journal of pathology,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
September 2014, Blood,
J Hirota, and T Osaki, and K Yoneda, and T Yamamoto, and E Ueta, and M Hiroi, and H Hara
January 1978, Giornale di clinica medica,
Copied contents to your clipboard!